Lexaria Bioscience Corp (LEXX)

[hdhick]

From “The Telegraph”


Ozempic maker reveals weight loss pill twice as effective as jab

The maker of weight loss drugs Ozempic and Wegovy has unveiled a new blockbuster obesity pill intended to help patients shed weight dramatically faster than its existing jabs.

Novo Nordisk said early trials for its experimental obesity drug amycretin revealed patients were able to lose more than 13pc of their weight after 12 weeks, compared to weight loss of around 6pc for its Wegovy treatment.

The Danish drugmaker makes both the weight-loss jab Wegovy and Ozempic, a diabetes drug used off-label to treat obesity.

It has been racing to keep up with ballooning demand for the treatments in the past few months, recording a 38pc jump in sales of weight-loss and obesity jabs in 2023 to DKK 215bn (£24bn).

Novo Nordisk chief executive Lars Fruergaard Jorgensen said on Thursday that the obesity market was “a tremendous runway”. Analysts forecast that it could be worth $90bn (£70bn) in the coming years.